1. Diffusion weighted imaging with reverse encoding distortion correction: Improvement of image quality and distortion for accurate ADC evaluation in in vitro and in vivo studies.
- Author
-
Furuta M, Ikeda H, Hanamatsu S, Yamamoto K, Shinohara M, Ikedo M, Yui M, Nagata H, Nomura M, Ueda T, Ozawa Y, Toyama H, and Ohno Y
- Subjects
- Humans, Reproducibility of Results, Head, Neck, Sensitivity and Specificity, Retrospective Studies, Diffusion Magnetic Resonance Imaging methods, Head and Neck Neoplasms diagnostic imaging
- Abstract
Purpose: The purpose of this in vivo study was to determine the effect of reverse encoding direction (RDC) on apparent diffusion coefficient (ADC) measurements and its efficacy for improving image quality and diagnostic performance for differentiating malignant from benign tumors on head and neck diffusion-weighted imaging (DWI)., Methods: Forty-eight patients with head and neck tumors underwent DWI with and without RDC and pathological examinations. Their tumors were then divided into two groups: malignant (n = 21) and benign (n = 27). To determine the utility of RDC for DWI, the difference in the deformation ratio (DR) between DWI and T2-weighted images of each tumor was determined for each tumor area. To compare ADC measurement accuracy of DWIs with and without RDC for each patient, ADC values for tumors and spinal cord were determined by using ROI measurements. To compare DR and ADC between two methods, Student's t-tests were performed. Then, ADC values were compared between malignant and benign tumors by Student's t-test on each DWI. Finally, sensitivity, specificity and accuracy were compared by means of McNemar's test., Results: DR of DWI with RDC was significantly smaller than that without RDC (p < 0.0001). There were significant differences in ADC between malignant and benign lesions on each DWI (p < 0.05). However, there were no significant difference of diagnostic accuracy between the two DWIs (p > 0.05)., Conclusion: RDC can improve image quality and distortion of DWI and may have potential for more accurate ADC evaluation and differentiation of malignant from benign head and neck tumors., Competing Interests: Declaration of competing interest This work was financially and technically supported by Canon Medical Systems Corporation, Japan. Drs. Nagata, Toyama and Ohno received research grants from Canon Medical Systems, Japan. Four of the authors (Ms. Kaori Yamamoto, Ms. Maiko Shinohara, Mr. Masato Ikedo and Mr. Masao Yui) are employees of Canon Medical Systems, Japan but did not have control over any of the data and information submitted for publication or which data and information were to be included in this study. None of the patients enrolled in this study were also entered in previous studies. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF